Northwire Canada EditionFriday, October 16, 2026
Sign inSubscribe
Northwire
⌕
GOLD 4170.10 +1.5% SILVER 57.16 +2.3% COPPER 6.56 −1.5% OIL 97.97 +3.0% PALLADIUM 1136.00 +3.6% LUN 32.91 +0.6% DLP 0.290 −3.3% VCV 0.065 −13.3% GG 2.89 +1.4% NBLC 0.015 +0.0% SF 0.300 −4.8% ATY 0.215 +2.4% GHL 0.060 −7.7% STND 0.060 −7.7% B 0.550 −3.5% HBM 34.33 −0.5% NTR 98.77 −0.7% SGZ 0.035 +0.0% MKA 0.670 +0.0% LXM 0.175 −18.6% CLCH 1.08 −1.8% GOLD 4170.10 +1.5% SILVER 57.16 +2.3% COPPER 6.56 −1.5% OIL 97.97 +3.0% PALLADIUM 1136.00 +3.6% LUN 32.91 +0.6% DLP 0.290 −3.3% VCV 0.065 −13.3% GG 2.89 +1.4% NBLC 0.015 +0.0% SF 0.300 −4.8% ATY 0.215 +2.4% GHL 0.060 −7.7% STND 0.060 −7.7% B 0.550 −3.5% HBM 34.33 −0.5% NTR 98.77 −0.7% SGZ 0.035 +0.0% MKA 0.670 +0.0% LXM 0.175 −18.6% CLCH 1.08 −1.8%

Healthcare

Page 39
  1. Mar 31, 2026 · 19:43 · 4565

    Not provided in data

    Nxera Pharma's Partner Centessa Pharmaceuticals to be Acquired by Lilly

    01
  2. Mar 31, 2026 · 19:10 · RVX

    Audit Delays and MCTO Mask Existential Liquidity Crisis at Resverlogix

    Resverlogix Corp. Provides Bi-Weekly MCTO Status Update

    02
  3. Mar 31, 2026 · 18:23 · MVMD

    Mountain Valley arranges offering, two debt settlements

    Mountain Valley arranges offering, two debt settlements

    03
  4. Mar 31, 2026 · 18:10 · IOT

    Innovotech Posts First Profitable Year as Stock Slides to Lows, Masking Thin Margins and Liquidity Risks

    Innovotech Inc. Reports Fourth Quarter and Full-Year 2025 Financial Results

    04
  5. Mar 31, 2026 · 18:10 · NXG

    Steady Growth Masks High Payout Ratio and Micro-Cap Liquidity Risks

    NexgenRx Announces 2025 Year End Results with Continued Increasing Net Income, EBITDA And Revenue Growth

    05
  6. Mar 31, 2026 · 17:22 · APS

    Aptose Shareholders Approve C$2.41 Hanmi Buyout as Clinical Data Validates Triplet Strategy

    Aptose Biosciences Announces Results of Special Shareholders Meeting; Announces Receipt of Final Court Approval of Plan of Arrangement; Reports Year End 2025 Results and Corporate Highlights

    06
  7. Mar 31, 2026 · 17:21 · TELO

    Telo Genomics appoints Farlinger as CEO, chairman

    Telo Genomics appoints Farlinger as CEO, chairman

    07
  8. Mar 31, 2026 · 16:15 · PINK

    Perimeter Clears FDA Hurdle and Posts Record Sales, But Cash Runway and Dilution Threaten Near-Term Upside

    Perimeter Announces Preliminary Unaudited Fourth Quarter and Full Year 2025 Financial Results Marked by Record Revenues and Improved Operating Performance

    08
  9. Mar 31, 2026 · 16:05 · BCT

    Internal License Transfer Closes as BriaCell Consolidates Pipeline Amid Cash Burn and Dilution Overhang

    BriaCell and BriaPro Announce Closing of Asset Purchase Transaction for Exclusive Soluble CD80 License

    09
  10. Mar 31, 2026 · 15:32 · THRM

    Therma Bright wins order for 100 Venowave units

    Therma Bright wins order for 100 Venowave units

    10
  11. Mar 31, 2026 · 15:25 · CHS

    Comprehensive Healthcare talks active sales pipeline

    Comprehensive Healthcare talks active sales pipeline

    11
  12. Mar 31, 2026 · 12:40 · AQS

    Aequus Offloads Final Asset for Half-Million as NEX Transfer Signals Corporate Wind-Down

    Aequus Announces Completion of Previously Announced Sale of ZIMED(R) PF

    12
  13. Mar 31, 2026 · 10:20 · INNO

    [Value]

    Innocan Pharma Announces Offering of an Additional Debenture to Tamar Innovest

    13
  14. Mar 31, 2026 · 08:50 · OTC

    Ocumetics Pivots to Partner Outreach as Clinical Data Meets Industry Scrutiny

    Ocumetics Technology Corp. Achieves Breakthrough in Next-Generation Accommodating Intraocular Lens Design

    14
← Newer Older →